Press release
Pleurisy Market Booms with 6.94% CAGR as North America and Europe Lead Global Surge
Pleurisy Market
Pleurisy Market is valued at USD 1.83 billion In 2024 and is expected to grow at the rate of CAGR of 6.94%, at the forecast period 2025-2032 and is expected to reach USD 3.23 billion by 2032 In 2024, Pleurisy Market Size was valued at approximately USD 720 million in North America and its Market share of 39.3%. Also, in Europe held a market share of 28% in the same year, equating to revenues of USD 510 million in 2024.
Use the provided link to get the sample report: https://www.stellarmr.com/report/req_sample/pleurisy-market/2612
Global Pleurisy Market Dynamics
The pleurisy market is driven by advancements in imaging technologies like CT, MRI, and ultrasound, aiding accurate diagnosis. However, misdiagnosis due to symptom overlap remains a challenge. Companies are investing in R&D for better diagnostics, while AI and telemedicine offer major growth opportunities, enhancing early detection and remote patient care.
Leading market Players Fueling Industry Evolution
Pfizer Inc. - New York City, United States, GlaxoSmithKline plc (GSK) - Brentford, United Kingdom and Novartis International AG - Basel These companies are not only pharmaceutical giants but also trendsetters in healthcare innovation, actively transforming patient care through precision medicine, AI diagnostics, mRNA platforms, and telemedicine.
Pleurisy is dominated by Type segment in terms of value, in 2024
This Pleurisy dominates the Pleurisy Market which the segment's value at USD 823.5 million holding 85% of market share in 2024. it is expected to hold the largest Pleurisy market share over the forecast period also as it has high prevalence rate there is also a high increase in hospitalization rate that is increases higher market demand for treatment.
Imaging Test is dominated by Diagnosis segment in terms of value, in 2024
This Diagnosis test dominates the Pleurisy Market which the segment's value at USD 0.73 billion holding 40% of market share in 2024. This dominance is attributed to the widespread adoption of advanced imaging technologies, which offer non-invasive, accurate, and rapid diagnostic capabilities.
For more detailed information, please refer to the full report: https://www.stellarmr.com/report/pleurisy-market/2612
Global Pleurisy Market Regional
North America is estimated to be the largest dominating region in terms of value, during the forecast period
This is the largest region in Pleurisy Market which the valued at approximately USD 720 million in North America and its Market share of 39.3% in 2024. It leads due to its advanced healthcare infrastructure, high R&D investments, strong presence of key pharmaceutical players, greater disease awareness, widespread use of AI and telemedicine, and the highest per capita healthcare spending.
Europe is estimated to be the Second-largest dominating region in terms of value, during the forecast period
This is the Second-largest region in Pleurisy Market which the valued at approximately USD 510 million in Europe and its Market share of 28% in 2024. It leads due to strong public healthcare systems, advanced diagnostic capabilities, major pharmaceutical companies, an aging population, and a high respiratory disease burden.
Pleurisy Market Competitive Landscape
Pfizer Inc.: Pfizer gained global attention through its collaboration with BioNTech for the development of the mRNA-based COVID-19 vaccine (Comirnaty). It focuses on mRNA technology, AI integration in R&D, and strategic acquisitions, such as Seagen (oncology). In 2024, this company generated USD 63.6 billion.
GlaxoSmithKline plc (GSK): GSK is a global biopharma company committed to developing innovative medicines and vaccines. In 2024, this company generated USD 42.1 billion. This company innovated mRNA vaccines, immunology, and oncology with ongoing investments in AI and bioelectronics (via Galvani Bioelectronics).
Novartis International AG: Novartis is a Swiss multinational pharmaceutical corporation known for its strong position in innovative medicines and generics. In 2024, this company generated USD 49.9 billion. It Leading in cell and gene therapies, radioligand therapy, and investing in digital health platforms.
To purchase the report, click this link: https://www.stellarmr.com/report/buy_now_report/pleurisy-market/2612
Emerging Trends in the Pleurisy Market
Pfizer is expanding its respiratory portfolio with next-generation vaccines such as Prevnar 20, emphasizing larger strain coverage and combination vaccinations to boost immunization efficiency.
Despite confronting issues with its RSV vaccine, Arexvy, GSK is investing in its respiratory and oncology pipelines, with a focus on early detection and tailored medication. Novartis is focusing on high-margin specialty pharmaceuticals and digital health solutions, with the goal of increasing yearly revenues by 6% by 2028 through operational efficiencies and novel therapies.
These programs demonstrate a dedication to enhancing pleurisy diagnosis and treatment through technological integration and focused medicines.
More Related Report:
Laptop Market https://www.stellarmr.com/report/Laptop-Market/2107
Potato Chips Market https://www.stellarmr.com/report/Potato-Chips-Market/1031
Parcel Delivery Market https://www.stellarmr.com/report/Parcel-Delivery-Market/393
Contact Stellar Market Research:
S.no.8, h.no. 4-8 Pl.7/4 Kothrud
Pinnac Memories Fl. No. 3
Kothrud, Pune, Maharashtra, 411029
sales@stellarmr.com
+91 9607365656
About Stellar Market Research:
Stellar Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pleurisy Market Booms with 6.94% CAGR as North America and Europe Lead Global Surge here
News-ID: 3974217 • Views: …
More Releases from STELLAR MARKET RESEARCH
Ready to Eat (RTE) Baked Products and Bakery Premixes Market Share, Industry Gro …
Ready to Eat (RTE) Baked Products and Bakery Premixes Market was estimated at USD 154.85 Bn. in 2024 and the total revenue is projected to grow at CAGR of 7% From 2025 to 2032 reaching nearly USD 231.41 Bn. by 2032.
Stellar Market Research published a report "Ready to Eat Baked Products and Bakery Premixes Market and forecast (2025-2032)." The report is a comprehensive analysis of global Ready to Eat Baked…
Micromotor Market Comprehensive Research Study, Competitive Landscape and Foreca …
Micromotor Market was estimated at USD 43.10 Bn in 2024, and its total revenue is projected to grow at a CAGR of 7.1% from 2025 to 2032, reaching nearly USD 69.66 Bn by 2032.
Stellar Market Research published a report "Micromotor Market and forecast (2025-2032)." The report is a comprehensive analysis of global Micromotor Market share, size, growth, trends, and forecast. The report also contains competitor analysis and regional analysis and…
Monkeypox Vaccine and Treatment Market Sales and Revenues of Manufacturers Forec …
Monkeypox Vaccine and Treatment Market size was estimated at USD 103.5 Mn in 2024 and the total Global Monkeypox Vaccine and Treatment revenue is projected to grow at a CAGR of 10.20% from 2025 to 2032, reaching nearly USD 225.12 Mn by 2032.
Stellar Market Research published a report "Monkey pox Vaccine and Treatment Market and forecast (2025-2032)." The report is a comprehensive analysis of global monkey pox Vaccine and Treatment…
K12 Education Market Dynamics, Competitive Landscape, Outlook 2025-2032
K12 Education Market Size was valued at USD 2.65 Tn in 2024 and is projected to grow at a CAGR of 12.6% from 2025 to 2032, reaching nearly USD 6.85 Tn by 2032.
Stellar Market Research has released a report "K12 Education Market and forecast (2025-2032)." The report is a detailed analysis of the global market share, size, growth, trends, and forecast of K12 Education Market. It also includes competitor and…
More Releases for Pleurisy
Pleurisy Market Trends and Analysis - Opportunities and Challenges for Future Gr …
Pleurisy Market Snapshot: Insight into Market Trends and Movements
Pleurisy is an inflammation of the pleura, the double-layered membrane surrounding the lungs, causing sharp chest pain and difficulty breathing.
The Pleurisy market is experiencing significant growth due to rising incidences of respiratory disorders, increased awareness about lung health, and advancements in diagnostic techniques. Emerging treatments and therapies aimed at alleviating symptoms contribute to market expansion, while the aging population further drives demand…
Pleurisy Market Analysis and Future Prospects for 2030
The world of the pleurisy market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing environment. We…
Pleurisy Disease Market is growing at a healthy CAGR of 6.10% by 2028
The pleurisy disease market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a healthy CAGR of 6.10% in the above-mentioned research forecast period.
Pleurisy is a disease in which the pleura, becomes inflamed. Also known as pleuritic, it causes chest pain, which worsens during breathing. If you have pleurisy, these tissues swell and become…
Splendid Growth of Pleurisy Diagnosis Market 2023 to 2030 |Size, In-Depth Qualit …
"Stratagem Market Insights offers a 70% discount on Pleurisy Diagnosis Market Reports on Single User Access and Unlimited User Access"
Overview
Pleurisy Diagnosis Market 2023 Forecast to 2030 research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current…
Pleurisy Diagnosis Market 2020 Recent Industry Developments and Growth Strategie …
To identify the scope of Global Pleurisy Diagnosis Market 2020, this report is prepared by in-depth analysis of historical data. The report forecasts the market size by the end of 2025 at an impressive CAGR provided by Reports and Reports. The report offers detailed outline of Pleurisy Diagnosis Market and vital market trends. The prime agenda of this report is to provide a detailed analysis of the global, regional and…
Pleurisy Market to Set Highest Record by Hefty Revenue till 2023 | Along with Pi …
There are wide market for pleurisy globally owing to increasing prevalence of chronic disease such as lung cancer, heart surgery, pancreatitis, chest trauma, autoimmune disorder, and asbestosis globally. These disease are consider as the leading causes for pleurisy. According to World Health Organization (WHO), in 2016, more than 90% of Chronic Obstructive Pulmonary Disease (COPD) deaths occur in the low and middle-income countries, also the Global Burden of Disease Study…
